Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2003
07/03/2003WO2003054549A2 Method of mass spectrometry
07/03/2003WO2003054544A2 Method for determination of the responsiveness of an individual to mistletoe lectin
07/03/2003WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries
07/03/2003WO2003054523A2 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array
07/03/2003WO2003054516A2 Devices and methods for isolating and detecting specific substances in complex matrices
07/03/2003WO2003054512A2 Identification of an amplified gene and target for drug intervention
07/03/2003WO2003054511A2 Methods for quantitating nucleic acids using coupled ligation and amplification
07/03/2003WO2003054509A2 Methods and devices for removal of organic molecules from biological mixtures using anion exchange
07/03/2003WO2003054234A1 Pcr based high throughput polypeptide screening
07/03/2003WO2003054233A1 Late-pcr
07/03/2003WO2003054232A2 Methods for removal of double-stranded oligonucleotides containing sequence errors using mismatch recognition proteins
07/03/2003WO2003054230A2 Detection of disease due to abnormal oestrogen levels
07/03/2003WO2003054229A2 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility
07/03/2003WO2003054228A2 Human cellular enzymes as targets against hepatitis c virus infections
07/03/2003WO2003054227A2 Method for the quantitative determination of gene expression
07/03/2003WO2003054226A2 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
07/03/2003WO2003054225A2 Method for determining nucleic acid analytes
07/03/2003WO2003054224A2 Method and integrated device for the detection of cytosine methylations
07/03/2003WO2003054223A2 Tripartite molecular beacons
07/03/2003WO2003054222A1 Screening for compounds useful in treating helicobacter pylori infection
07/03/2003WO2003054221A1 Imp dehydrogenase and the use of the same for identifying fungicidally active compounds
07/03/2003WO2003054220A1 Reporter gene assay method
07/03/2003WO2003054218A2 Nucleotide polymorphisms associated with osteoporosis
07/03/2003WO2003054214A2 Tsunami chain reaction - geometric dna amplification
07/03/2003WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE
07/03/2003WO2003054212A2 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna
07/03/2003WO2003054211A2 Receptors for hypersensitive response elicitors and uses thereof
07/03/2003WO2003054209A2 A method of reducing non-specific amplification in pcr
07/03/2003WO2003054203A1 Isolation tool for viable c-kit expressing cells
07/03/2003WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
07/03/2003WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof
07/03/2003WO2003054193A2 Raf/ras binding compounds
07/03/2003WO2003054192A1 Method of identifying gibberellin responsive gene using cultured vegetable cells
07/03/2003WO2003054186A1 New rennets
07/03/2003WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease
07/03/2003WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
07/03/2003WO2003054181A2 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants
07/03/2003WO2003054180A1 Modified mek1 and mek2, crystal of a peptide: ligand: cofactor complex containing such modified mek1 or mek2, and methods of use thereof
07/03/2003WO2003054177A2 New glycosyl hydrolases
07/03/2003WO2003054167A2 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
07/03/2003WO2003054166A2 Nucleotide polymorphisms associated with osteoarthritis
07/03/2003WO2003054159A2 Modulating insulin receptor signaling through targeting facl
07/03/2003WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same
07/03/2003WO2003054157A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
07/03/2003WO2003054156A2 Novel g proein-coupled receptor, gave7
07/03/2003WO2003054155A2 Pichia pastoris formate dehydrogenase and uses therefor
07/03/2003WO2003054149A2 Targeted genetic risk-stratification using microarrays
07/03/2003WO2003054143A2 Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
07/03/2003WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054139A2 Compositions and methods utilizing dna polymerases
07/03/2003WO2003054138A1 Cell culture instrument and method of separating and subculturing cells
07/03/2003WO2003054016A2 Method for cloning of variable domain sequences
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003054011A2 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
07/03/2003WO2003054005A2 Bone polypeptide-1
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053934A1 Improved compounds for generating chemiluminescence with a peroxidase
07/03/2003WO2003053921A2 Mutant proteinase inhibitors and uses thereof
07/03/2003WO2003053857A1 Forming and modifying dielctrically-engineered microparticles
07/03/2003WO2003053855A2 Rapid high-throughput screen for detecting biological species in ballast water
07/03/2003WO2003053535A2 Nanoparticle imaging system and method
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053338A2 Novel chimeric rev, tat, and nef antigens
07/03/2003WO2003053224A2 Novel compositions and methods for cancer
07/03/2003WO2003053223A2 Prostate cancer diagnosis and outcome prediction by expression analysis
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053215A2 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
07/03/2003WO2003053139A1 Disruption of the phosphodiesterase 10 gene
07/03/2003WO2003053138A1 Transgenic expression of glycogen synthase kinase 3 in muscle
07/03/2003WO2003042398A3 Multiplexed analysis by chromatographic separation of molecular tags
07/03/2003WO2003041490A3 Novel isoamylases and associated methods and products
07/03/2003WO2003040684A3 Screening for antiviral affecting signal peptidase
07/03/2003WO2003034038A3 Flow control metering system and method for controlling filtration of liquid-based specimens
07/03/2003WO2003029435A3 Detection of polynucleotide hybridization
07/03/2003WO2003018761A3 Compositions and methods for generating antigen-binding units
07/03/2003WO2003017038A3 A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003012040A3 Mutant nurr1 gene in parkinson's disease
07/03/2003WO2003006623A3 Directed protein modificaiton by iterative sequence insertion
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002100163A3 Cotton event moni5985 and compositions and methods for detection
07/03/2003WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/03/2003WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures
07/03/2003WO2002090572A3 Nucleic acid detection in pooled samples
07/03/2003WO2002088379A3 Methods and compositions for utilizing changes of hybridization signals during approach to equilibrium
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002061149A3 A quantitative assay for nucleic acids
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002050285A3 Histone deacetylase-related gene and protein
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002031203A9 High throughput or capillary-based screening for a bioactivity or biomolecule
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002020849A3 Gene markers useful for detecting skin damage in response to ultraviolet radiation
07/03/2003WO2002016653A3 Methods and systems for facilitating the diagnosis and treatment of schizophrenia
07/03/2003WO2002014867A3 Ultra-sensitive detection systems
1 ... 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 ... 3003